Sep 19, 2014 at 17:04 | Source: CNBC-TV18
After this 11-day long audit, where the FDA just took a break just on Sunday; they are expected to wrap up its inspections by the end of the day.
Sep 19, 2014 at 15:02 | Source: CNBC-TV18
Akshata Deshmukh of Networth Stock Broking is of the view that one may hold Sun Pharmaceutical Industries.
Sep 19, 2014 at 13:38 | Source: Moneycontrol.com
In a recent report, brokerage firm Ambit recently put out its latest findings in its greatness series wherein it tries to identify which Indian companies are poised to enter the most productive phases of their lifecycles.
Sep 19, 2014 at 08:22 | Source: CNBC-TV18
Manas Jaiswal of manasjaiswal.com advises buying Unitech with a target of Rs 29 and Adani Power with a target of Rs 57.
Sep 18, 2014 at 12:28 | Source: CNBC-TV18
Sanju Verma, CEO at Violet Arc Global Managers is of the view that one may prefer pharma stocks, Tata Steel from the metal space and Ambuja Cements from the cement space.
Sep 18, 2014 at 12:18 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, capital goods stocks like Crompton Greaves, Siemens, ABB, Bharat Heavy Electricals and Havells India will be getting astrological support.
Sep 18, 2014 at 12:05 | Source: CNBC-TV18
Market Expert, Ambareesh Baliga is of the view that one may buy Sun Pharmaceutical Industries.
Sep 18, 2014 at 12:00 | Source: CNBC-TV18
R Sreesankar, Head of Institutional Equities at Prabhudas Lilladher is extremely bullish on the Indian IT sector.
Sep 18, 2014 at 10:49 | Source: Moneycontrol.com
Morgan Stanley remains overweight on the stock, though it estimates a USD 400 million sales hurdle rate for Sun to generate meaningful return on investment (ROI) with possible launch by 2017.
Sep 18, 2014 at 10:01 | Source: CNBC-TV18
Verma is upbeat on Lupin despite its continuous run, but has reservations about Sun Pharma.